live Iran warns of confrontation if U.S. blockade persists - Thursday, 30 April
A senior adviser to Iran’s Supreme Leader warned the U.S. port blockade would fail, saying Tehran has ways to bypass it and could turn to con...
French pharmaceutical giant Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines for $9.1 billion to strengthen its portfolio in rare immunological diseases.
France-based pharmaceutical company Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines Corporation for $9.1 billion, in a strategic move to bolster its presence in rare immunological diseases.
Blueprint, a biopharmaceutical company specializing in systemic mastocytosis (SM) and other KIT-driven diseases, accepted Sanofi’s offer of $129 per share in cash. The offer represents a 27% premium over Blueprint’s last closing price of $101.35 on Friday.
The acquisition includes Ayvakit (avapritinib), a treatment for SM approved in both the U.S. and EU, along with a robust early- and late-stage immunology pipeline.
“Blueprint’s established relationships with allergists, dermatologists, and immunologists are expected to enhance Sanofi’s growing immunology portfolio,” the French company said in a statement.
The transaction is expected to close in the third quarter of 2025, pending regulatory approvals.
As part of the deal, Blueprint shareholders will also receive one non-tradeable contingent value right (CVR), entitling them to potential milestone payments of $2 and $4 per CVR based on future achievements.
Blueprint is currently the only company with an approved drug for systemic mastocytosis - a rare disorder caused by excess mast cells - and is also developing next-generation therapies for SM and other immune disorders.
The acquisition marks the largest healthcare M&A deal in Europe so far this year. It follows Sanofi’s recent purchase of Vigil Neuroscience for $470 million last month - the second time the French company has acquired Vigil in 2025, after an initial purchase in January.
A Pentagon official provided the first official estimate of the cost of the U.S. war in Iran on Wednesday (29 April), telling lawmakers that $25 billion had so far been spent on the conflict, most of it on munitions. Earlier, Donald Trump said that the U.S. had "militarily defeated" Tehran.
Tensions between the United States and Iran remain high after a U.S. official said President Donald Trump was unhappy with a proposal from Tehran that does not deal with its nuclear programme. Washington is insisting that any talks must address Iran’s nuclear activities.
The decision by the United Arab Emirates to leave OPEC+ on 1 May has put renewed focus on one of the most influential groups in global energy - and how its decisions can shape oil prices worldwide.
Mexican special forces arrested Audias Flores, known as “El Jardinero”, a senior commander of the powerful Jalisco New Generation Cartel (CJNG), during an operation in the western state of Nayarit, Security Minister Omar García Harfuch said on Monday (27 April).
The United Arab Emirates has said it's quitting OPEC from 1 May, dealing a major blow to the oil producers’ group and its de facto leader, Saudi Arabia, amid disruption caused by the Iran war.
Jars of baby food deliberately tampered with rat poison and discovered in Austria, the Czech Republic and Slovakia were part of an attempted extortion plot targeting manufacturer HiPP, German police said on Monday.
More than half of Haiti’s population is facing acute food insecurity, prompting the United Nations World Food Programme (WFP) to warn that recent progress in tackling hunger remains fragile and could quickly be reversed without urgent support.
A Chinese biotechnology company is stepping up efforts to combine artificial intelligence (AI) with advanced genetic testing in a bid to improve the success rates of in vitro fertilization (IVF), while also tapping into growing demand for fertility services.
Austria’s government on Friday approved plans to introduce a nationwide ban on social media use for children under the age of 14, alongside reforms to upper secondary school curricula aimed at boosting media literacy and Artificial Intelligence (AI) education from the 2027/28 academic year.
The UK Health Security Agency (UKHSA) said that as of Wednesday evening, it has identified six new cases of meningococcal disease in Kent, bringing the total of confirmed or suspected cases to at least 27.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment